Yuko Kaneko

6.8k total citations
293 papers, 3.8k citations indexed

About

Yuko Kaneko is a scholar working on Rheumatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Yuko Kaneko has authored 293 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Rheumatology, 60 papers in Epidemiology and 55 papers in Pathology and Forensic Medicine. Recurrent topics in Yuko Kaneko's work include Rheumatoid Arthritis Research and Therapies (95 papers), Systemic Lupus Erythematosus Research (53 papers) and Autoimmune and Inflammatory Disorders Research (38 papers). Yuko Kaneko is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (95 papers), Systemic Lupus Erythematosus Research (53 papers) and Autoimmune and Inflammatory Disorders Research (38 papers). Yuko Kaneko collaborates with scholars based in Japan, United States and United Kingdom. Yuko Kaneko's co-authors include Tsutomu Takeuchi, Mitsuhiro Akiyama, Kunihiro Yamaoka, Masataka Kuwana, Hidekata Yasuoka, Katsuya Suzuki, Hideto Kameda, Naoshi Nishina, Takehiko Saito and Harumi Kondo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuko Kaneko

262 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Kaneko Japan 32 2.1k 817 727 633 594 293 3.8k
Shigeto Tohma Japan 33 1.6k 0.8× 462 0.6× 968 1.3× 578 0.9× 408 0.7× 182 3.5k
Mami Tamai Japan 30 1.7k 0.8× 399 0.5× 1.0k 1.4× 689 1.1× 414 0.7× 219 3.4k
Lucile Musset France 40 2.0k 1.0× 1.8k 2.2× 1.1k 1.6× 513 0.8× 301 0.5× 82 5.1k
M. Hamidou France 38 1.3k 0.6× 720 0.9× 1.2k 1.7× 795 1.3× 1.0k 1.7× 229 4.4k
Francesco Trotta Italy 36 1.9k 0.9× 429 0.5× 891 1.2× 516 0.8× 516 0.9× 154 3.6k
Franco Franceschini Italy 37 2.4k 1.1× 1.2k 1.4× 1.3k 1.8× 403 0.6× 296 0.5× 210 4.6k
Yackov Berkun Israel 38 1.2k 0.6× 322 0.4× 1.3k 1.7× 1.2k 1.9× 666 1.1× 120 4.0k
Margit Zeher Hungary 39 1.6k 0.8× 572 0.7× 1.6k 2.2× 653 1.0× 328 0.6× 147 4.5k
Michel De Bandt France 28 1.3k 0.6× 362 0.4× 693 1.0× 402 0.6× 506 0.9× 81 2.7k
Yasushi Kawaguchi Japan 39 1.5k 0.7× 1.3k 1.6× 1.3k 1.7× 813 1.3× 451 0.8× 141 4.1k

Countries citing papers authored by Yuko Kaneko

Since Specialization
Citations

This map shows the geographic impact of Yuko Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Kaneko more than expected).

Fields of papers citing papers by Yuko Kaneko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Kaneko. The network helps show where Yuko Kaneko may publish in the future.

Co-authorship network of co-authors of Yuko Kaneko

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Kaneko. A scholar is included among the top collaborators of Yuko Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Kaneko. Yuko Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyama, Mitsuhiro, et al.. (2025). Efficacy of tocilizumab monotherapy for autoimmune hemolytic anemia associated with idiopathic multicentric Castleman disease: a case-based review. Rheumatology International. 45(5). 113–113. 1 indexed citations
2.
Ishigaki, Sho, Katsuya Suzuki, Masaru Takeshita, & Yuko Kaneko. (2025). Identification of BHLHE40 ‐Expressing CD4 + T Cells Producing GM ‐ CSF in Rheumatoid Arthritis. International Journal of Rheumatic Diseases. 28(4). e70219–e70219.
3.
4.
5.
Akiyama, Mitsuhiro, et al.. (2024). Human T follicular helper cells and their impact on IgE and IgG4 production across allergy, malignancy, and IgG4-related disease. Allergology International. 74(1). 25–32. 6 indexed citations
6.
Akiyama, Mitsuhiro, et al.. (2024). Long-term efficacy of sarilumab on the progression of interstitial lung disease in rheumatoid arthritis: the KEIO-RA cohort and literature review. Clinical and Experimental Rheumatology. 43(3). 451–458. 2 indexed citations
7.
Saito, Shuntaro, Hironari Hanaoka, Jun Kikuchi, et al.. (2024). Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis. Arthritis & Rheumatology. 77(3). 298–310. 3 indexed citations
8.
Ito, Yoshihiro, et al.. (2024). Apremilast is a Potentially Useful Treatment for Severe Palmoplantar Pustulosis with Extra-Palmoplantar Symptoms. SHILAP Revista de lepidopterología. 4(2). e336–e336. 2 indexed citations
9.
Takanashi, Satoshi & Yuko Kaneko. (2024). Unmet Needs and Current Challenges of Rheumatoid Arthritis: Difficult-to-Treat Rheumatoid Arthritis and Late-Onset Rheumatoid Arthritis. Journal of Clinical Medicine. 13(24). 7594–7594. 6 indexed citations
10.
Akiyama, Mitsuhiro, et al.. (2024). Successful treatment of Crohn’s disease-related peripheral spondyloarthritis with upadacitinib: two case reports and case-based review. Rheumatology International. 44(12). 3127–3133. 1 indexed citations
11.
Inamo, Jun, Akari Suzuki, Mahoko Takahashi Ueda, et al.. (2024). Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms. Nature Communications. 15(1). 4285–4285. 10 indexed citations
12.
Akiyama, Mitsuhiro, Yasushi Kondo, Shuntaro Saito, et al.. (2023). Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine. Autoimmunity Reviews. 22(5). 103307–103307. 1 indexed citations
13.
Hanaoka, Hironari, et al.. (2023). Sarcopenia in patients with rheumatic musculoskeletal diseases. International Journal of Rheumatic Diseases. 26(10). 2007–2013. 4 indexed citations
14.
Furuta, Shunsuke, Daiki Nakagomi, Y Kobayashi, et al.. (2023). Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study. Annals of the Rheumatic Diseases. 83(1). 96–102. 12 indexed citations
15.
Tanaka, Hiromu, Takanori Asakura, Jun Kikuchi, et al.. (2022). Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept). SHILAP Revista de lepidopterología. 1 indexed citations
16.
17.
18.
Kaneko, Yuko, Masataka Kuwana, Hideto Kameda, & Tsutomu Takeuchi. (2011). Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria. Lara D. Veeken. 50(7). 1268–1274. 57 indexed citations
19.
20.
Kaneko, Yuko, Gen Matsumoto, & Yoshiro Hanyu. (1999). Pax‐6 expression during retinal regeneration in the adult newt. Development Growth & Differentiation. 41(6). 723–729. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeto Tohma Breakdown of academic impact, for papers by Mami Tamai Breakdown of academic impact, for papers by Lucile Musset Breakdown of academic impact, for papers by M. Hamidou Breakdown of academic impact, for papers by Francesco Trotta Breakdown of academic impact, for papers by Franco Franceschini Breakdown of academic impact, for papers by Yackov Berkun Breakdown of academic impact, for papers by Margit Zeher Breakdown of academic impact, for papers by Michel De Bandt Breakdown of academic impact, for papers by Yasushi Kawaguchi
Rankless by CCL
2026